Arch Therapeutics, Inc. has appointed Chirag Shah, PhD as Vice President of Research and Development Engineering and Quality Systems, effective April 7, 2014, and has appointed Peter A. LaCrosse as Chief of Staff, effective immediately. Dr. Shah brings a proven record with 20 years of experience in advanced research and product development, technology assessment, and device performance evaluations for advanced wound care, vascular and infection control products. Prior to joining Arch Therapeutics, Dr. Shah spent a decade at Covidien, where he was a Senior Director of the Biomaterials Research and Development Center of Excellence in Vascular Therapies and contributed to peripheral, neurovascular, wound care and renal access products and technologies development.

Peter A. LaCrosse is joining as the company's Chief of Staff, bringing 11 years of high level operations experience and 15 years of military experience.